The Leadership Team at Coave Therapeutics is responsible for setting the strategic direction and operational oversight of the company. Comprising key executives such as the CEO, COO, and Chief Development Officer, the team collaborates to drive innovation in gene therapy, ensure legal and regulatory compliance, and ultimately enhance patient outcomes for rare ophthalmic diseases. Their collective expertise guides the company's mission to preserve visual autonomy for affected individuals.
View all